Claritin and Irbesartan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Claritin (loratadine) and Irbesartan (irbesartan). Common drug interactions include constipation among females and decreased appetite among males.
The phase IV clinical study analyzes what interactions people have when they take Claritin and Irbesartan. It is created by eHealthMe based on reports of 143 people who take the same drugs from the FDA, and is updated regularly.
What is Claritin?
Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,316 Claritin users. Check the latest studies of Claritin.
What is Irbesartan?
Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,414 Irbesartan users. Check the latest studies of Irbesartan.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
143 people who take Claritin and Irbesartan together, and have interactions are studied.

What are the common drug interactions of Claritin and Irbesartan, by gender? *
What are the common drug interactions of Claritin and Irbesartan, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Claritin and Irbesartan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Claritin (77,316 reports)
- Irbesartan (36,414 reports)
Browse all drug interactions of Claritin and Irbesartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Claritin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Irbesartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Claritin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Irbesartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on loratadine and irbesartan (the active ingredients of Claritin and Irbesartan, respectively), and Claritin and Irbesartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Metastatic Malignant Melanoma and Squamous Cell Carcinoma Of Skin - a second ago
- Could Tart Cherry cause Cough Aggravated? - 6 seconds ago
- Could Tapazole cause Pneumonia? - 8 seconds ago
- Gabapentin and Tekturna drug interactions for women aged 60+ - 8 seconds ago
- Drug interactions of Gemfibrozil and Ondansetron - 12 seconds ago
- Could Ranexa cause Fatigue? - 12 seconds ago
- Gingival Hypertrophy and drugs of ingredients of cyclosporine - 17 seconds ago
- Could Lopurin cause Gingival Hypertrophy? - 27 seconds ago
- Could Tamsulosin Hydrochloride cause Blood Lactate Dehydrogenase Increased? - 34 seconds ago
- Could Novorapid cause Angioedema? - 38 seconds ago